March 04, 2008; 70 (10) Articles
Bevacizumab for recurrent malignant gliomas
Efficacy, toxicity, and patterns of recurrence
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen
First published March 3, 2008, DOI: https://doi.org/10.1212/01.wnl.0000304121.57857.38
A. D. Norden
G. S. Young
K. Setayesh
A. Muzikansky
R. Klufas
G. L. Ross
A. S. Ciampa
L. G. Ebbeling
B. Levy
J. Drappatz
S. Kesari
Bevacizumab for recurrent malignant gliomas
Efficacy, toxicity, and patterns of recurrence
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen
Neurology Mar 2008, 70 (10) 779-787; DOI: 10.1212/01.wnl.0000304121.57857.38
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 70 no. 10 779-787
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published March 3, 2008.
Copyright & Usage:
© 2008
Author Disclosures
- A. D. Norden, MD,
- G. S. Young, MD,
- K. Setayesh, MA,
- A. Muzikansky, MA,
- R. Klufas, MD,
- G. L. Ross, MD,
- A. S. Ciampa, NP,
- L. G. Ebbeling, BA,
- B. Levy, BA,
- J. Drappatz, MD,
- S. Kesari, MD, PhD and
- P. Y. Wen, MD
- A. D. Norden, MD,
- G. S. Young, MD,
- K. Setayesh, MA,
- A. Muzikansky, MA,
- R. Klufas, MD,
- G. L. Ross, MD,
- A. S. Ciampa, NP,
- L. G. Ebbeling, BA,
- B. Levy, BA,
- J. Drappatz, MD,
- S. Kesari, MD, PhD and
- P. Y. Wen, MD
- From the Division of Cancer Neurology (A.D.N., A.S.C., L.G.E., B.L., J.D., S.K., P.Y.W.), Department of Neurology, Brigham and Women's Hospital and Center For Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School; Brigham and Women's Hospital Department of Radiology and Harvard Medical School (G.S.Y., K.S., R.K., G.L.R.); and Massachusetts General Hospital Biostatistics Center (A.M.), Boston.
- Address correspondence and reprint requests to Dr Norden, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, SW430B, 44 Binney St., Boston, MA 02115 anorden{at}partners.org
Article usage
Cited By...
Letters: Rapid online correspondence
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- Marc C. Chamberlain, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, POB 19023, MS G4940, Seattle, WA 98109-1023chambemc@u.washington.edu
Submitted June 04, 2008 - Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- Maciej M. Mrugala, University of Washington/Fred Hutchinson Cancer Research Center, 1959 NE Pacific Street, Seattle, WA 98195mmrugala@u.washington.edu
Submitted June 04, 2008 - Reply from the Authors
- Andrew D Norden, Brigham and Women's Hospital, 44 Binney St, Boston, MA 02115anorden@partners.org
- Geoffrey S. Young, Patrick Y. Wen
Submitted June 04, 2008
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan